33 results
8-K
ALPN
Alpine Immune Sciences Inc
21 Dec 23
Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie
4:23pm
to provide AbbVie with a data package based on the Analysis and including certain information described in the Amendment (the “Revised Data Package … ”). AbbVie may exercise the Option until its expiration 90 days following the date the Company delivers to AbbVie the Revised Data Package, subject
8-K
EX-99.1
mzg86x
21 Dec 23
Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie
4:23pm
424B5
c0baeg60j jjey
7 Nov 23
Prospectus supplement for primary offering
8:15pm
424B5
qmgzti3fh 988e8
6 Nov 23
Prospectus supplement for primary offering
6:05am
424B5
bohj8pyt
11 May 23
Prospectus supplement for primary offering
4:43pm
424B5
q02wtegn3olzba7y3
21 Sep 22
Prospectus supplement for primary offering
5:18pm
424B5
ebtq5fqkq515c03b67
20 Sep 22
Prospectus supplement for primary offering
4:20pm